Monoamiergic neurons use dopa decarboxylase (DDC; aromatic-L-amino-acid carboxy-lyase, EC 4.1.1.28) to form dopamine from L-3,4-dihydroxyphenylalanine (L-dopa). We measured regional dopa decarboxylase activity in brains of six healthy volunteers with 6-[18F]fluoro-L-dopa and positron emission tomography. We calculated the enzyme activity, relative to its K., with a kinetic model that yielded the relative rate of conversion of 6['8Flfluoro-L-dopa to [18Fjfluorodopamine. Regional values of relative dopa decarboxylase activity ranged from nil in occipital cortex to 1.9 h-1 in caudate nucleus and putamen, in agreement with values obtained in vitro.
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The accumulation of metabolites of 6-[18F]fluoro-L-dopa (Fdopa) in brain reflects the activity of dopa decarboxylase (DDC; aromatic-L-amino-acid carboxy-lyase, EC 4.1.1.28), the enzyme responsible for the formation of dopamine from dopa (3,4-dihydroxyphenylalanine) (1) (2) (3) . Unlike tyrosine hydroxylase, this enzyme is believed not to be regulated in response to the intensity of dopaminergic neurotransmission (4) . Therefore, DDC activity may be a more precise indicator of the tissue's capacity to synthesize dopamine than tyrosine hydroxylase, the activity of which is adjusted to compensate for changes of dopaminergic activity.
Recently, we used Fdopa to measure the relative activity ofDDC in vivo in rat brain (5) . We defined the relative activity as the ratio between the reaction velocity and the enzyme precursor content ofthe tissue-i.e., proportional to the ratio between the enzyme's maximal velocity and the halfsaturation concentration of precursor when the precursor concentration is negligible relative to the half-saturation Michaelis constant Km (see Eqs. 7 and 8) . In rat brain, the relative enzyme activity was as low as 1% of the relative activity reported in vitro. The reason for the discrepancy was unknown, but we speculated that it most probably was the loss of labeled fluorodopamine or its metabolites from one or more pools of dopamine in the tissue.
In the present study, we obtained the relative activity of DDC in human brain in vivo. In vitro, the monoamine oxidase activities are lower in human brain than in rat brain (see Discussion) , and metabolite diffusion distances are longer. For these reasons, we predicted the human relative DDC activity, determined in striatum in vivo with positron emission tomography (PET), to be close to the relative rate of dopamine synthesis determined in vitro.
METHODS
A model of the transport and metabolism of Fdopa in brain in vivo must include the compartments and transfer coefficients shown in Fig. 1 . The model describes the methylation of Fdopa in the circulation (actually in peripheral organs), the loss of methyl-Fdopa from the circulation, the methylation of Fdopa in brain tissue, the exchange of Fdopa and methylFdopa between the circulation and brain tissue, and the decarboxylation of Fdopa in the tissue. The model has too many compartments to be evaluated by PET. We used known relationships between the parameters to reduce the number of compartments to three and the number of parameters to four: We incorporated into each study (i) the ratio (0.43) between the blood-brain barrier transport rates of Fdopa and methyl-Fdopa in rat (5) Me Km(Vd +i 1) [7] where Vm. is the maximal velocity of the native decarboxylation reaction in vivo, v is the velocity of native dopamine synthesis in vivo, Me is the native dopa content of the tissue, Km is the Michaelis half-saturation concentration of native dopa, Vd is the water volume of brain tissue (assumed to be the distribution volume for Fdopa), Mi represents the contents of n inhibitors in the tissue (including dopa and Fdopa), and Ki represents the inhibitory constant of the n inhibitors.
The definition of k' for Fdopa is (KmVD 8 [4] (ith and we where VI, is the maximal velocity of the tracer reaction in vivo, and KI is the Michaelis half-saturation concentration of [5] the tracer. Hence, the decarboxylase activity toward Fdopa is linearly proportional to the activity toward native dopa. [11] This equation has three unknowns, Ki VO, and k3, when M*(T), CD(t), CM(t), C*(T), Ve, and q are known.
Procures. The subjects included six healthy 19-to 42-yearold volunteers (mean age, 28 years), studied in accordance with an experimental protocol approved by the Ethics Committee of the Montreal Neurological Institute and Hospital.
Informed consent was obtained after full explanation of the nature and possible consequences of the studies. The subjects were treated with 100 mg of carbidopa 1 h before the study to inhibit peripheral decarboxylation of Fdopa to fluorodopamine and were injected with 5 mCi (1 Ci = 37 GBq) of Fdopa, which circulated for 120 min. At a specific activity of 300 mCi-mmol-1, the mass (6) .
In the PET images, anatomical regions were identified in a computerized atlas of the human brain, with the aid of magnetic resonance images obtained in association with the PET images, by the method of Evans et al. (7) . In three subjects, the three planes were acquired 23 ± 6, 35 ± 6, and 47 ± 6 mm (mean ± SD) above the orbito-meatal line. In the three remaining subjects, the three planes were interleaved at 31 ± 2, 43 ± 2, and 55 ± 2 mm above the orbito-meatal line.
The regionally recorded radioactivities were fitted by Eq. planes in all subjects) or relative DDC activity (kD, higher two planes in all subjects) (Fig. 1) . The coefficient of peripheral methylation, ko, was determined by HPLC analysis. Arterial blood time-radioactivity curves of total radioactivity, Fdopa radioactivity, and methyl-Fdopa radioactivity were established on the basis of the arterial samples and the HPLC measurements. The synthesis of Fdopa and the HPLC analysis of Fdopa and metabolites in plasma have been described in detail (5) . Carbidopa was a gift from Merck.
RESULTS
Representative magnetic resonance and PET image planes of one subject are shown in Fig. 2 Left and Right. The regions outlined in Fig. 2 Right were identified from a computerized atlas applied to the magnetic resonance image shown in Fig.   2 Left.
Determination of kD. The rate constant of conversion of Fdopa to methyl-Fdopa-i.e., the relative catechol-Omethyltransferase activity-k I, was calculated from Eq. 2 as exemplified for one subject in Fig. 3 Fig. 2 after i .v. injection of 5 mCi of Fdopa. Region 2 is the left middle frontal gyrus, and region 11 is the left putamen. In this example, ko averaged 0.66 h-'. By using the values q = 2.3 and Ve = 0.40 ml-cm-', the radioactivity recorded in the two regions was subjected to nonlinear least-squares regression analysis by Eq. 0.54 ± 0.04 h-' (mean ± SEM). The ordinate intercept, the rate constant for elimination of methyl-Fdopa from the circulation, -k0h, averaged -0.36 ± 0.36 h-1 and hence was insignificantly different from zero. The magnitude of k0 suggested that the magnitude of k0, the coefficient of methylation in brain tissue, is of the order of 0.05 h-1, or <5% of the magnitude of k' in caudate nucleus and putamen.
Determination of Ve. Using the predetermined value of q (2.3; ref. 5), we estimated the value of Ve in the lowest two planes of the tomographic images (23 ± 6 and 31 ± 2 mm above the orbito-meatal line). The average value of the six brains was 0.52 ± 0.06 mlcm-3 (mean ± SEM). The corresponding estimate of K1 was 1.68 + 0.18 ml cm-3 h-1 (mean + SEM).
Determination of k3. We used the value of Ve determined for each subject to estimate the regional values of Kp, the blood-brain clearance of Fdopa, and kI, the coefficient of metabolism of Fdopa, by means of Eq. 11. The analysis oftwo regions ofthe same plane from a single subject is shown in Fig.  4 . The results for all regions of interest are listed in Table 1 . Results obtained in the lowest planes were not listed because these were used to determined Ve, as explained above. Table 1 includes the average distance of a given tomographic plane from the orbito-meatal line, the volume of First, the finite resolution of the imaging system used (12 mm x 12 mm x 12 mm) resulted in systematic loss of signal from smaller structures-i.e., the partial volume effect (10-'12) . For isolated structures of high radioactivity, this reduces the amplitude but not the shape of the time-radioactivity curve. The result is decreases of K1 and V0 but not of k2 and k3. Partial volume effects for large isolated "hot spots," such as the striatum, are of secondary importance. For smaller structures, the contamination from neighboring tissue will be significant, and the resultant k3 may be an underestimate of DDC activity in the amygdala and hippocampus.
Second, a fraction of newly formed dopamine is subject to very rapid breakdown by monoamine oxidase, the activity of which is so high that little free dopamine is likely to exist outside the storage vesicles of monoaminergic terminals. In rodent striatum, the activity of monoamine oxidase A is 120 Amolg-lh-', indicating a concentration of dopamine available for oxidation (e.g., the dopamine outside vesicles) of no more than 30 nM at the rate of dopamine turnover determined in rodent striatum. Hence, the half-life of intracellular free dopamine may be no more than 2 s (13). This deduction suggests that only labeled fluorodopamine stored in vesicles remains in situ sufficiently long to be recorded by PET. The significance ofthe rapid breakdown depends, ofcourse, on the speed with which labeled metabolites escape from the regions ofinterest and on the fraction offluorodopamine not protected from immediate metabolism by incorporation into vesicles. In rat, in vivo estimates ofrelative DDC activity using the present model and manual tissue sampling suggested that as little as 1% of newly formed dopamine entered vesicles or remained otherwise protected from rapid metabolism.
In the humans studied here, however, the relative DDC activities determined in striatum and surrounding cortical regions agree reasonably well with the in vitro measurements (14) (15) (16) (17) . The good correlation indicates that Fdopa, in humans, is converted to metabolites that leave the regions of interest slowly. In rat, as much as 86% of total dopamine oxidation (monoamine oxidases A and B) in caudate nucleus takes place intraneuronally, whereas in humans, only 18% of total dopamine oxidation in caudate nucleus is intraneuronal (18) . Also, total monoamine oxidase activity in human caudate, measured in vitro, is 1-10 umol'g-1lh-1 (17, 19) or at least 1 order of magnitude less than the monoamine oxidase activity of rat striatum.
